Bortezomib vs no bortezomib
Health‐related quality of life · All patients with a diagnosis of multiple myeloma
1 finding from 1 review
- no estimate extracted4 studies · 717 participantsGRADE not reported
Findings
What do systematic reviews say?
2 questions · 2 findings · 2 reviews
No studies found 1 · 50%GRADE not reported 1 · 50%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Intervention not reported
Quality of life · newly diagnosed, transplant‐ineligible adults with symptomatic multiple myeloma
The review found no eligible studies for this question.
1 finding from 1 review
- Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with… 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found